StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Baxter (BAX) Receives CE Mark for PrisMax
October 29, 2018 7:12 AM
Baxter International Inc. (NYSE: BAX), a global leader in acute care, announced today the company received CE mark of both ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Management Comments
Next Articles
Baxter (BAX) Tops Q3 EPS by 6c, Revenues Beat; Offers FY18 EPS Outlook
October 31, 2018 7:16 AM
Baxter Receives CE Mark for PrisMax, the Next-Generation System for Continuous Renal Replacement and Organ Support Therapies
October 29, 2018 7:00 AM